NASDAQ:NRC - Nasdaq - US6373722023 - Common Stock - Currency: USD
NASDAQ:NRC (3/3/2025, 2:49:07 PM)
14.12
-0.47 (-3.22%)
The current stock price of NRC is 14.12 USD. In the past month the price decreased by -12.74%. In the past year, price decreased by -64.03%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 11.36 | 85.03B | ||
CVS | CVS HEALTH CORP | 11.99 | 81.78B | ||
LH | LABCORP HOLDINGS INC | 17.47 | 21.23B | ||
DGX | QUEST DIAGNOSTICS INC | 19.63 | 19.66B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 16.1 | 13.79B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 144.53 | 11.83B | ||
DVA | DAVITA INC | 15.18 | 11.82B | ||
HIMS | HIMS & HERS HEALTH INC | 77.33 | 9.12B | ||
CHE | CHEMED CORP | 25.54 | 8.85B | ||
OPCH | OPTION CARE HEALTH INC | 28.19 | 5.85B | ||
CRVL | CORVEL CORP | 26.24 | 5.63B | ||
GH | GUARDANT HEALTH INC | N/A | 5.22B |
National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. The company is headquartered in Lincoln, Nebraska and currently employs 435 full-time employees. Its digital solutions consist of three primary solution categories: Marketing, Reputation and Experience. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. The firm's Experience solutions are provided on a subscription basis via a cross-continuum multi-mode digital platform. Its Reputation solutions allow healthcare organizations to share a picture of their organization.
NATIONAL RESEARCH CORP
1245 Q Street
Lincoln NEBRASKA 68508 US
CEO: Michael D. Hays
Employees: 435
Company Website: http://nrchealth.com/
Phone: 14024752525
The current stock price of NRC is 14.12 USD. The price decreased by -3.22% in the last trading session.
The exchange symbol of NATIONAL RESEARCH CORP is NRC and it is listed on the Nasdaq exchange.
NRC stock is listed on the Nasdaq exchange.
NATIONAL RESEARCH CORP (NRC) has a market capitalization of 325.89M USD. This makes NRC a Small Cap stock.
NATIONAL RESEARCH CORP (NRC) currently has 435 employees.
NATIONAL RESEARCH CORP (NRC) has a resistance level at 17.02. Check the full technical report for a detailed analysis of NRC support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NATIONAL RESEARCH CORP (NRC) has a dividend yield of 3.31%. The yearly dividend amount is currently 1.49. Check the full fundamental report for a detailed analysis of NRC dividend history, reliability and sustainability.
The PE ratio for NATIONAL RESEARCH CORP (NRC) is 11.3. This is based on the reported non-GAAP earnings per share of 1.25 and the current share price of 14.12 USD. Check the full fundamental report for a full analysis of the valuation metrics for NRC.
The outstanding short interest for NATIONAL RESEARCH CORP (NRC) is 1.96% of its float. Check the ownership tab for more information on the NRC short interest.
ChartMill assigns a fundamental rating of 5 / 10 to NRC. NRC scores excellent on profitability, but there are some minor concerns on its financial health.
Over the last trailing twelve months NRC reported a non-GAAP Earnings per Share(EPS) of 1.25. The EPS decreased by -3.12% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 18.78% | ||
ROA | 20.54% | ||
ROE | 78.2% | ||
Debt/Equity | 1.44 |
ChartMill assigns a Buy % Consensus number of 45% to NRC. The Buy consensus is the average rating of analysts ratings from 8 analysts.